Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT
Lantern Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 100.65K | 100.65K | 100.65K | 261.05K | 261.05K | 261.05K | 261.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 52.43K | 98.7K | 139.27K | 183.59K | 179.05K | 176.54K | 174.84K | 130.53K | 126.3K | 121.08K | 115.77K | 186.87K | 147.77K | 134.92K | 98.12K | 27.02K | 27.02K | 1.34K |
Gross Profit | -2.1K | -48.37K | -88.94K | 77.47K | 82K | 84.51K | 86.21K | -130.53K | -126.3K | -121.08K | -115.77K | -186.87K | -147.77K | -134.92K | -98.12K | -27.02K | -27.02K | -1.34K |
Operating Income | -20.5M | -21.26M | -22.22M | -21.2M | -19.54M | -19.32M | -17.88M | -16.83M | -15.45M | -14.65M | -14.43M | -14.12M | -16.12M | -14.21M | -12.59M | -11.98M | -9.53M | -7.88M |
Interest Income | 617.28K | 691.2K | 742.36K | 848.35K | 903.39K | 832.56K | 765.39K | 572.68K | 378.51K | 315.72K | 204.35K | 129.67K | 154.67K | 147.53K | 125.11K | 125.11K | 47.89K | n/a |
Pretax Income | -19.25M | -19.88M | -20.78M | -19.09M | -17.75M | -17.53M | -15.96M | -15.16M | -14.26M | -14.01M | -14.26M | -14.42M | -16.21M | -14.03M | -12.36M | -11.72M | -9.37M | -7.88M |
Net Income | -19.25M | -19.88M | -20.78M | -19.09M | -17.75M | -17.53M | -15.54M | -14.74M | -13.96M | -13.8M | -14.53M | -14.69M | -16.36M | -14.09M | -12.36M | -11.72M | -9.37M | -7.88M |
Selling & General & Admin | 6.18M | 6.07M | 6.04M | 5.67M | 5.52M | 5.68M | 5.94M | 6.25M | 6.38M | 6.16M | 5.83M | 5.6M | 5.35M | 5.25M | 5.02M | 5.22M | 5.14M | 4.5M |
Research & Development | 14.32M | 15.14M | 16.13M | 15.43M | 13.92M | 13.59M | 11.89M | 10.57M | 9.07M | 8.5M | 8.6M | 8.51M | 10.78M | 8.95M | 7.57M | 6.76M | 4.39M | 3.39M |
Other Expenses | n/a | 46.27K | 46.27K | 90.58K | 90.58K | 44.32K | 329.04K | 284.72K | 113.07K | 113.07K | -171.65K | -143.5K | 45.83K | 160.55K | 160.55K | 132.4K | 114.72K | n/a |
Operating Expenses | 20.5M | 21.26M | 22.21M | 21.19M | 19.54M | 19.32M | 17.88M | 16.83M | 15.45M | 14.65M | 14.43M | 14.12M | 16.12M | 14.21M | 12.59M | 11.98M | 9.53M | 7.88M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.03K | 29.03K | 29.03K | 29.03K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -46.27K | -50.33K | -94.64K | -94.64K | -48.38K | -44.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.85M | 21.26M | 22.22M | 21.2M | 19.54M | 19.32M | 17.88M | 16.83M | 15.45M | 14.65M | 14.43M | 14.12M | 16.12M | 14.21M | 12.59M | 11.98M | 9.53M | 7.88M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -418.5K | -418.5K | -299.08K | -201.51K | 272.37K | 301.4K | 181.97K | 84.41K | 29.04K | 5.00 | 5.00 | 5.00 |
Shares Outstanding (Basic) | 10.78M | 10.78M | 10.78M | 10.76M | 10.76M | 10.74M | 10.8M | 10.86M | 10.86M | 10.86M | 10.85M | 10.84M | 10.83M | 10.88M | 11.17M | 11.19M | 11.18M | 10.07M |
Shares Outstanding (Diluted) | 10.78M | 10.78M | 10.78M | 10.76M | 10.76M | 10.74M | 10.8M | 10.86M | 10.86M | 10.86M | 10.85M | 10.84M | 10.83M | 10.88M | 11.19M | 11.19M | 11.18M | 10.07M |
EPS (Basic) | -1.78 | -1.84 | -1.93 | -1.78 | -1.65 | -1.63 | -1.44 | -1.36 | -1.29 | -1.27 | -1.33 | -1.34 | -1.48 | -1.27 | -1.13 | -1.28 | -1.19 | -1.12 |
EPS (Diluted) | -1.78 | -1.84 | -1.93 | -1.78 | -1.65 | -1.63 | -1.44 | -1.36 | -1.29 | -1.27 | -1.33 | -1.34 | -1.48 | -1.27 | -1.13 | -1.28 | -1.19 | -1.12 |
EBITDA | -20.49M | -21.24M | -22.2M | -21.18M | -19.53M | -19.31M | -17.86M | -16.81M | -15.44M | -14.64M | -14.42M | -14.07M | -16.07M | -14.16M | -12.54M | -11.97M | -9.52M | -7.88M |
EBIT | -15.85M | -21.26M | -22.22M | -21.2M | -19.54M | -19.32M | -17.88M | -16.83M | -15.45M | -14.65M | -14.43M | -14.15M | -16.15M | -14.23M | -12.62M | -11.98M | -9.53M | -7.88M |
Depreciation & Amortization | 13.54K | 17.8K | 17.28K | 16.68K | 16K | 55.51K | 94.89K | 93.67K | 129.06K | 123.83K | 118.53K | 186.87K | 149.62K | 136.76K | 99.97K | 29.96K | 29.21K | 4.2K |